The current clinical landscape of personalized cancer vaccines

The earliest known form of immunotherapy was performed by the American surgeon William Coley in 1890 who treated cancer patients with streptococcal bacterial cultures (dubbed “Coley’s toxin”) and observed tumor regression in some cases [1]. Since then, tremendous amount of work has demonstrated that the human immune system can indeed prevent, control and eradicate cancer cells [1]. Cancer immunotherapy can be classified into two main categories, i.e. passive or act ive, based on their mode of actions.
Source: Cancer Treatment Reviews - Category: Cancer & Oncology Authors: Source Type: research